Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Verrica Pharmaceuticals

Verrica Pharmaceuticals?uq=PEM9b6PF
2013 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
VRCA STOCK SYMBOL
$9.60 SHARE PRICE (As of Monday Closing)
Description

Developer of a biopharmaceutical platform designed to develop innovative therapies for common skin diseases. The company's platform focuses on identifying, developing and commercializing innovative therapies to unmet needs in medical dermatology thereby helping patients to have less pain and time-consuming treatment, enabling dermatologists to better administer cantharidin for warts and skin diseases.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • Durham, NC
  • United States

+1 (610) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Verrica Pharmaceuticals’s full profile, request a free trial.

Verrica Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$9.60 - $20.34 $258M $10.04 -$0.83 58.7K 25.7M

Verrica Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 314,417
Revenue 0 0 0
EBITDA (16,617) (4,457) (1,913)
Net Income (16,007) (4,459) (1,913) (1,913)
Total Assets 98,805 9,083 544
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Verrica Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Verrica Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Verrica Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Verrica Pharmaceuticals Executive Team (6)

Name Title Board
Seat
Contact
Info
Ted White Chief Executive Officer & President
James Reebals Chief Financial Officer
Jayson Rieger Ph.D Chief Operating Officer & Board Member
Matthew Davidson Ph.D Founder, Chief Scientific Officer & Board Member

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Verrica Pharmaceuticals Board Members (5)

Name Representing Role Since Contact
Info
Glenn Oclassen Verrica Pharmaceuticals Board Member & Advisor 000 0000
Jayson Rieger Ph.D Verrica Pharmaceuticals Chief Operating Officer & Board Member 000 0000
Matthew Davidson Ph.D Verrica Pharmaceuticals Founder, Chief Scientific Officer & Board Member 000 0000
Paul Manning PBM Capital Group Board Member 000 0000
Sean Stalfort Verrica Pharmaceuticals Board Member 000 0000